EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
We have previously described the role played by toxic-metal burdens in the etiology of neurodegenerative diseases (ND). We herein report an updated evaluation of toxic-metal burdens in human subjects affected or not affected by ND or other chronic diseases. Each subject underwent a chelation test wi...
Main Authors: | Alessandro Fulgenzi, Daniele Vietti, Maria Elena Ferrero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/8/269 |
Similar Items
-
Neuron Protection by EDTA May Explain the Successful Outcomes of Toxic Metal Chelation Therapy in Neurodegenerative Diseases
by: Maria Elena Ferrero
Published: (2022-10-01) -
Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline
by: Yorinobu Maeda, et al.
Published: (2023-05-01) -
Alleviation of salinity stress by EDTA chelated-biochar and arbuscular mycorrhizal fungi on maize via modulation of antioxidants activity and biochemical attributes
by: Ping Huang, et al.
Published: (2024-01-01) -
Study of Chelating Agent—Surfactant Interactions on the Interphase as Possibly Useful for the Well Stimulation
by: Timur Ildarovich Yunusov, et al.
Published: (2023-02-01) -
A COMPARISON OF THE EFFECT OF MINERAL AND CHELATE FORMS OF COPPER, ZINC AND MANGANESE ON YIELD AND NUTRIENT STATUS OF GREENHOUSE LETTUCE
by: Elżbieta Kozik, et al.
Published: (2012-02-01)